£13,000 or His Life: The Hidden Cost of NHS Waiting Lists

A powerful report by Maya Wilson Autzen in the Daily Telegraph exposes a stark reality facing UK families: when the NHS cannot deliver timely care, patients are forced to choose between financial strain and worsening health. As waiting lists stretch and costs rise, more people are turning to private treatment they can barely afford. Increasingly, access to essential surgery depends not on need, but on the ability to pay.

Judith Stephenson did not expect to take on debt in her late forties. But when faced with a simple choice – find £13,000 or risk her father’s life – she had no real alternative.

As reported by Maya Wilson Autzen, her 87-year-old father, David Fine, had become bed-bound due to a failing hip. The consequences were immediate. Repeated bouts of pneumonia, triggered by immobility, saw him in and out of hospital. Without surgery, his condition would only deteriorate.

The NHS waiting time for a hip replacement was one year. “He would have died otherwise,” Stephenson said. So she took out a loan. In January 2023, her father underwent surgery privately – a decision that likely saved his life, but left lasting financial pressure. Just over a year later, her 83-year-old mother needed a shoulder replacement. Another £18,000. Another loan.

Stephenson’s situation is no longer unusual. It reflects a growing reality across the UK.

“You have to weigh up whether you can afford for them to have an operation,” she said. “If you can’t, does that mean you’re going to lose them?”

A System Under Pressure

NHS waiting lists currently stand at more than 7 million treatment pathways in England. However, survey data suggests the real impact is even wider, with around one in five adults reporting that they are currently waiting for some form of NHS care. For many, those waits are long. According to NHS England, 62% of patients still wait more than 18 weeks for treatment.

Orthopaedics is the most pressured area. More than 860,000 people are waiting for trauma and orthopaedic procedures – including hip and knee replacements – making it the largest single queue in the NHS. These are not minor conditions. Delays often mean loss of mobility, independence and, in some cases, serious deterioration in overall health.

“Pay or Wait” Is Becoming “Pay or Die”

Even former NHS professionals are turning away from the system. Carole, a former NHS physiotherapist, faces an 18-month wait for a knee replacement. Unable to tolerate the pain, she is considering remortgaging her home to raise £16,000. “My life has completely changed,” she said. “Now I can’t even sit on the floor with my grandchild.”

Others report similar experiences. Rebecca spent two years navigating misdiagnosis before turning to private care, now facing a £20,000 bill. Leslie, after a distressing experience in A&E, was told she would wait two years for treatment and instead borrowed £9,000. Her conclusion was blunt: “You pay or you die.”

The Rise of Self-Pay Healthcare

The UK’s self-pay healthcare market is now valued at £1.6 billion, as more patients fund treatment directly rather than rely on insurance. This shift is driven by necessity. Healthwatch England data shows that 16% of people used private healthcare in 2025, up from 9% in 2023, with 39% citing NHS waiting times as the reason.

Private sector activity reflects the same trend, with 898,000 private hospital admissions in 2023 and a 39% increase in self-pay treatments compared to pre-pandemic levels.

At the same time, private medical insurance is becoming less viable for many. Only 12–14% of the population is covered, and premiums rise sharply with age. Stephenson’s parents, like many others, were forced to cancel cover when costs reached £1,200 per month.

As a result, patients are increasingly choosing to pay for treatment when they need it. This shift is also extending beyond the UK, with more than 520,000 patients estimated to have travelled abroad for treatment in 2025.

Patients are no longer waiting passively – they are acting, paying and finding alternatives. What is emerging is a quiet but profound reversal of the NHS’s founding principle. A system designed to provide equal access to care is increasingly creating a divide between those who can afford to bypass delays and those who cannot. This is not the result of policy intent, but of structural pressure. When waiting becomes the default, access is no longer determined solely by clinical need, but by the ability to pay to avoid it.

A New Pathway for Patients Who Cannot Wait

Against this backdrop, new models of care are emerging to address the gap between urgency and access. MMG is preparing to launch to the UK market a significant suite of orthopaedic treatments through high-quality private hospitals across the European Union. The offering will cover knee, hip, shoulder, spine and ACL procedures – the areas most affected by NHS delays.

The model is built around speed and certainty. Following remote diagnostic review – now widely accepted, including within the NHS – patients are offered three confirmed surgery dates within six weeks.

At the same time, MMG treatment packages are significantly less expensive than UK private alternatives. Greater competition and a deeper supply of private hospitals across Europe allow for more competitive pricing without compromising clinical quality.

Crucially, the pathway extends beyond surgery. MMG offers a complete treatment package, including post-operative care and physiotherapy – a notable departure from the UK private model, where rehabilitation is usually separate and harder to access.

Patients also retain continuity of care once they return home. They remain under the supervision of the treating hospital in Europe, while continuing to have access to NHS services in the event of any emergency.

For a growing number of orthopaedic patients in the UK, the issue is no longer whether they are willing to seek alternatives. It is whether they can afford not to. And increasingly, the answer is forcing them to look beyond the system they once relied on.